Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Health status instruments / utilities

N Bellamy1, M Boers, D Felson

  • 1Department of Medicine, University of Western Ontario, London, Canada.

The Journal of Rheumatology
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large-scale molecular endotype discovery in synovial fluid reveals osteoarthritis as a single biological continuum.

Nature communications·2026
Same author

Presence of erosions is not a risk factor for the development of knee OA in a hand OA population: Results from the Framingham OA study.

Osteoarthritis and cartilage open·2025
Same author

Knee braces for knee osteoarthritis: A scoping review and narrative synthesis of interventions in randomised controlled trials.

Osteoarthritis and cartilage·2024
Same author

Correlation of serum level of squamous cell carcinoma antigen with severity of cutaneous psoriasis, assessed using the simplified psoriasis index.

Annales de dermatologie et de venereologie·2024
Same author

Lagrangian Supersaturation Fluctuations at the Cloud Edge.

Physical review letters·2024
Same author

Reflections from the OARSI 2022 clinical trials symposium: The pain of OA-Deconstruction of pain and patient-reported outcome measures for the benefit of patients and clinical trial design.

Osteoarthritis and cartilage·2023
Same journal

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

The Journal of rheumatology·2026
Same journal

Concurrent Calcium Pyrophosphate Deposition Disease and Gout of the Cervical Spine Presenting With Subacute Neck Pain and Radiculopathy.

The Journal of rheumatology·2026
Same journal

The Need for Weight Communication Guidelines in Pediatric Rheumatology.

The Journal of rheumatology·2026
Same journal

Bimekizumab Improves Health Status and Work Productivity, With Reduced Productivity Costs, to 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.

The Journal of rheumatology·2026
Same journal

Qualitative Analysis of Physical Activity Engagement in Women with Self-Reported SLE: The Role of Symptoms, Healthcare Providers, and the Environment.

The Journal of rheumatology·2026
Same journal

Tumoral Calcinosis-like Calcification of the Proximal Interphalangeal Joint Mimicking Rheumatoid Arthritis Flare.

The Journal of rheumatology·2026
See all related articles

Generic health status instruments are not yet suitable for musculoskeletal disease trials due to concerns about validity and responsiveness. Further research is needed to validate and improve these measures for reliable health policy decisions.

Area of Science:

  • Rheumatology
  • Health Outcomes Research

Background:

  • Musculoskeletal disease trials face challenges in comparing health status across different conditions.
  • Generic health status instruments offer potential for cross-disease comparisons but require validation.

Framework:

  • OMERACT II conference participants convened to assess the utility of generic health status instruments in rheumatology research.
  • Concerns were raised regarding the comprehensiveness and responsiveness of existing instruments.

Implementation:

  • Physicians expressed limited personal experience with generic health status instruments.
  • Key health dimensions relevant to musculoskeletal diseases were found to be underrepresented.
  • The absence of adverse effects measurement was noted as a limitation.

Related Experiment Videos

Implications:

  • Limited response categories and lack of comprehensiveness suggest potentially low responsiveness of current instruments.
  • Further research, including adoption in trials and observational studies, is crucial for validating and refining generic measures.
  • Current generic measures are insufficient for establishing valid conclusions and informing health policy in musculoskeletal diseases.